Taking Risk Prediction to the Next Level. Advances in Biomarker Research for Atherosclerosis

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|33|5929-5941

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.33, 2013-10, pp. : 5929-5941

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advances in Biomarker Research for Pancreatic Cancer

By  

Current Pharmaceutical Design, Vol. 18, Iss. 17, 2012-06 ,pp. : 2439-2451

Bentham Science Publishers

Access to resources Recommend Favorite

The Canadian Biomarker Integration Network in Depression (CAN-BIND): Advances in Response Prediction

By  

Current Pharmaceutical Design, Vol. 18, Iss. 36, 2012-12 ,pp. : 5976-5989

Bentham Science Publishers

Access to resources Recommend Favorite

Mitochondrial genome sequencing in atherosclerosis: what's next?

By  

Current Pharmaceutical Design, Vol. 22, Iss. 3, 2016-01 ,pp. : 390-396

Bentham Science Publishers

Access to resources Recommend Favorite

Environmental Risk Assessment of Arsenic and Fluoride in the Chaco Province, Argentina: Research Advances

By Buchhamer Edgar E.   Blanes Patricia S.   Osicka Rosa M.   Giménez M. Cecilia  

Journal of Toxicology and Environmental Health, Vol. 75, Iss. 22-23, 2012-11 ,pp. : 1437-1450

Taylor & Francis Ltd

Access to resources Recommend Favorite

Oral contraceptives and the risk of thrombosis and atherosclerosis

By Barton Matthias   Dubey Raghvendra K   Traupe Tobias  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 3, 2002-03 ,pp. : 329-332

Informa Healthcare

Access to resources Recommend Favorite